Amgen Stock Drops 040% in Second Consecutive Day of Decline Ranking 127th in Trading Volume

On April 2, 2025, Amgen's trading volume reached $581 million, a 37.92% decrease from the previous day, ranking 127th in the day's stock market. Amgen's stock price fell by 0.40%, marking the second consecutive day of decline, with a total decrease of 1.88% over the past two days.

Amgen's CEO, Bob Bradway, released a letter to shareholders highlighting the company's strong performance in 2024. This positive outlook from the CEO may have influenced investor sentiment, contributing to the stock's recent movements.

Amgen's stock has shown resilience, with a 52-week high of $346.85 and a low of $253.30, indicating a range within which the stock has traded over the past year. The company's beta of 0.52 suggests that its stock price movements are less volatile compared to the overall market.